RNA therapeutics for neurological disease
Author:
- 24 January 2024
- book chapter
- Published by Elsevier
- Vol. 203, 165-180
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- In vitro RNA SELEX for the generation of chemically-optimized therapeutic RNA drugsMethods, 2016
- Antisense targeting of 3′ end elements involved inDUX4mRNA processing is an efficient therapeutic strategy for facioscapulohumeral dystrophy: a new gene-silencing approachHuman Molecular Genetics, 2016
- A Brief History of Triplet Repeat Diseases2013
- Targeting RNA splicing for disease therapyWIREs RNA, 2013
- Parkinson's Disease: Genetics and PathogenesisAnnual Review of Pathology: Mechanisms of Disease, 2011
- Non-ATG–initiated translation directed by microsatellite expansionsProceedings of the National Academy of Sciences, 2010
- Duchenne muscular dystrophy and dystrophin: pathogenesis and opportunities for treatmentEMBO Reports, 2004
- Myotonic Dystrophy Mutation: an Unstable CTG Repeat in the 3′ Untranslated region of the GeneScience, 1992
- Molecular basis of myotonic dystrophy: Expansion of a trinucleotide (CTG) repeat at the 3′ end of a transcript encoding a protein kinase family memberCell, 1992
- The scanning model for translation: an update.Journal of Cell Biology, 1989